Although peptides like BPC 157 are not yet FDA-approved, we are seeing promising results in patients seeking relief from a variety of injuries, chronic pain, and inflammation
You deserve care that adapts to your goals and works with your biology, not against it
Tirzepatide holds both signals on for a week, allowing the drug to reach appetite centers and metabolic tissues that a short meal signal barely reaches. The two signals are not balanced
Side Effects and Risks of DSIP Because DSIP is still in the research stage, its safety profile is not fully understood
The degradation rate and half-life (t1/2) of the drugs were determined by measuring the decrease in area under the curve (AUC) at their retention times [2]
preferred with heart failure or CKD per ADA 2026 Sulfonylureas (glipizide, glimepiride, glyburide): Stimulate insulin secretion